Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Granulocyte Colony-Stimulating Factor. Found 6 abstracts

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18):1895-901.   PMCID: PMC4050203
Plimack ER, Hoffman-Censits J, Rosenberg JE, Wong YN, Bellmunt J, Choueiri TK. Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye [Letter]. J Clin Oncol. 2014 Dec 20;32(36):4171-2.
Saez B, Ferraro F, Yusuf RZ, Cook CM, Yu VW, Pardo-Saganta A, Sykes SM, Palchaudhuri R, Schajnovitz A, Lotinun S, Lymperi S, Mendez-Ferrer S, Toro RD, Day R, Vasic R, Acharya SS, Baron R, Lin CP, Yamaguchi Y, Wagers AJ, Scadden DT. Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning. Blood. 2014 Nov 06;124(19):2937-47.   PMCID: Pmc4224192
Fleming GF, Fowler JM, Waggoner SE, Copeland LJ, Greer BE, Horowitz I, Sutton G, Schilder RJ, Fracasso PM, Ball HG, McGuire WP. Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study. J Clin Oncol. 2001 Feb 15;19(4):1021-9.
Movsas B, Hudes RS, Schol J, Millenson M, Rosvold E, Nicolaou N, Litwin S, Wang H, Keenan E, Curran WJ, Langer CJ. Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report. Clinical lung cancer. 2001 Jan;3(2):125-32.
Schilder RJ, Goldberg M, Millenson MM, Movsas B, Rogatko A, Rogers B, Langer CJ. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer. 2000 Jan;27(1):37-45.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Granulocyte Colony-Stimulating Factor

Male Granulocyte Colony-Stimulating Factor Female Aged Antineoplastic Combined Chemotherapy Protocols therapeutic use drug effects Paclitaxel Middle Age methods Drug Administration Schedule drug therapy administration & dosage Bone Marrow effects Cisplatin Human Treatment Outcome Hematopoietic Stem Cell Mobilization Disease-Free Survival Adult Hematopoietic Stem Cell Transplantation Disease Progression analysis adverse Combined Modality Therapy Protective Agents pathology chemistry Doxorubicin Lung Neoplasms Transitional Cell Carcinoma Carboplatin Urinary Bladder Neoplasms Neoadjuvant Therapy genetics Squamous Cell Carcinoma Drug Dose-Response Relationship Cystectomy Treatment Outcomes Fatigue biosynthesis Heparin dt [Drug Therapy] ad [Administration and Dosage] Feasibility Studies Radiation Dosage Gene Expression Profiling pharmacology Middle Aged Inbred C57BL Mice US Gov't Support-PHS Adenocarcinoma N-Acetylglucosaminyltransferases Experimental Diabetes Mellitus adverse effects Peripheral Nerves Methotrexate Survival administration & Recombinant Proteins Kaplan-Meier Estimate Anticoagulants immunology radiotherapy Neoplasm Invasiveness Transplantation Conditioning 80 and over Aged Green Fluorescent Proteins Biological Tumor Markers Heparitin Sulfate Clinical Assessment Tools Funding Source Signal Transduction Filgrastim Neoplasm Staging Endometrial Neoplasms ae [Adverse Effects] Non-Small-Cell Lung Carcinoma Heart Female Genital Neoplasms dosage Tumor Biomarkers Karnofsky Performance Status Stromal Cells metabolism rt [Radiotherapy] tu [Therapeutic use] Adjuvant Chemotherapy Competitive Binding Non-US Gov't Support Vinblastine Thoracotomy chemically induced Transgenic Mice Vascular Cell Adhesion Molecule-1 therapy Polyethylene Glycols Prospective Studies
Last updated on Friday, August 14, 2020